Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

CYTOTOOLS AG (T5O)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 12/15 05:36:03 pm
11.865 EUR   -1.45%
11/30 CYTOTOOLS : Invest_Yorkville
11/30 CYTOTOOLS AG : Submission of the European clinical trials for the wo..
05/09 CYTOTOOLS : withdraws planned convertible bond
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Xetra
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
12.125(c) 11.6(c) 12(c) 12.04(c) 11.865(c) Last
3 458 5 624 1 175 5 371 311 Volume
-2.41% -4.33% +3.45% +0.33% -1.45% Change
More quotes
Company
CytoTools AG is an investment holding company, which engages in the development of therapies to treat cause of diseases.It provides treatment options in dermatology, cardiology and angiology, urology, and oncology.Its pipeline includes DermaPro, CardioClean, LMW 0x, Cancer T17-n, and Utisept.The... 
More about the company
Latest news on CYTOTOOLS AG
11/30 CYTOTOOLS : Invest_Yorkville
11/30 CYTOTOOLS AG : Submission of the European clinical trials for the wound healing ..
05/09 CYTOTOOLS : withdraws planned convertible bond
04/25 CYTOTOOLS : Capital increase
04/25 CYTOTOOLS : Ad hoc Capital increase
04/21 DGAP-NEWS : CytoTools AG schafft mit Kapitalerhöhung die Voraussetzung zur Umset..
04/21 DGAP-ADHOC : CytoTools AG schafft mit einer Barkapitalerhöhung die Voraussetzung..
04/07 DGAP-NEWS : Produktionsstart in Indien
03/30 DGAP-ADHOC : Ausgabe einer Wandelanleihe mit einem Gesamtnennbetrag von bis zu 0..
03/24 DGAP-NEWS : CytoTools AG: DermaPro(R) erhält Marktzulassung in Indien - ein Meil..
More news
Sector news : Bio Therapeutic Drugs
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
More sector news : Bio Therapeutic Drugs
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Mark-Andre Freyberg Chief Executive Officer
Manfred May Chairman-Supervisory Board
Matthias Hoffmann Member-Supervisory Board
Peter Friedl Deputy Chairman-Supervisory Board
Rüdiger Weseloh Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG40.02%29
GILEAD SCIENCES6.94%97 083
REGENERON PHARMACEUTICALS5.33%41 162
VERTEX PHARMACEUTICALS96.55%36 046
GENMAB-11.85%10 015
BLUEBIRD BIO INC199.68%8 449